NL-OMON49918已完成4 期
Pharmacokinetic cross-over study of compounded chenodeoxycholic acid - CDCA-PK
Amsterdam UMC0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Be 18 years of age or older
- •- Be a male
- •- Have a BMI between 18,5 and 30 kg/m2
- •- Able and willing to swallow the capsules
- •- Able to undergo blood sampling for PK analysis
- •- Able and willing to give written informed consent
- •- Willing to follow the dietary restrictions
- •- Able to complete the study
排除标准
- •- Inability to give informed consent
- •- Hypersensitivity to one of the components in either product
- •- moking or use of other tobacco products
- •- History of alcohol or drug abuse
- •- Use of co-medication
- •- Gastrointestinal disease that may impact the absorption
- •- Metabolic or endocrine disease
- •- Gallbladder disease and/or removal
- •- Liver disease
- •- Participation in another clinical trial during or in the 3 months prior to
研究者
相似试验
进行中（未招募）
1 期
Pharmacology of pharmacy prepared chenodeoxycholic acid.CTXCTEUCTR2021-003823-14-NLAmsterdam UMC12
已完成
4 期
Study on pharmacy prepared CDCA capsules<p>Cerebrotendinous Xanthomatosis</p>10014699NL-OMON23443Amsterdam UMC12
尚未招募
不适用
A Pharmacokinetic Study of Camylofin fixed dose combination with Paracetamol in healthy participantsCTRI/2021/03/032174ot Applicable
进行中（未招募）
1 期
A study of uptake and effects of the opioid antidote naloxone given as a nasal spray in children.EUCTR2017-000379-96-SEKarolinska University Hospital
已完成
2 期
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.Metastatic castration-resistant prostate cancer10038597NL-OMON50053Erasmus MC, Universitair Medisch Centrum Rotterdam20